To further illuminate the molecular mechanisms of MBD2 in HNSCC, our study assessed the efficacy of shRNA MBD2 and 5‐Aza treatment in TU212 and AMC‐HN8 two HNSCC cell models. This evidence concerns the gene MBD2 and head and neck squamous cell carcinoma.